Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Posts Fallen Revenue, Narrowed Loss in Q4

NEW YORK, Feb. 20 - Pyrosequencing today reported a slight decrease in total revenue, curtailed R&D spending, and a narrowed net loss.


Total receipts for the period ended Dec. 31 were $3.9 million compared with $4.3 million for the same time last year, Pyrosequencing said. The company attributed the decline to poor exchange rates between the Swedish krona and the US dollar and euro.


R&D spending in the quarter, meantime, was cut to $30.3 million from $42.8 million year over year. As a result, net loss narrowed to $5.5 million, or $.16 per share, from $6.2 million, or $.18 per share, in the fourth quarter 2001.


Pyrosequencing said it had roughly $54 million in cash, cash equivalents, and investments in high-grade debt securities as of Dec. 31.


Click here for more information.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.